The country’s health regulator began an accelerated review for the COVID-19 vaccine candidate AstraZenec is developing with the University of Oxford. Regulators are conducting a “rolling review,” meaning they will examine clinical trial data in real time while planning with the drugmaker about manufacturing and distribution.
The U.K. is also speeding up the review process for Pfizer’s COVID-19 vaccine candidate, Bloomberg reported Oct. 31.
More articles on pharmacy:
Ascension launches pharmacy services business Ascension Rx
6 recent pharma industry exec moves
FDA lists essential medicines, countermeasures and pharmaceutical ingredients
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
